Neuropathic Pain: a Personal Case Reflection on a Critical Incident

Overview

Journal Indian J Palliat Care

Specialty Critical Care

Date 2011 Oct 7

PMID 21976858

Citations 1

Authors

Balaji P Duraisamy

Manjiri P Dighe

Maryann A Muckaden

Affiliations

Soon will be listed here.

Abstract

Neuropathic pain is a distressing symptom for the patient and a difficult symptom for the physician to treat. There is lack of evidence-based clinical guidelines for the management of malignant neuropathic pain. The case reflection is a personal account of what has been learnt from a critical incident in a particular patient in the management of neuropathic pain. Psychological issues are known to increase pain percetion and affect the quality of life. The case reflection explores problem areas, defines lacunae in knowledge, and demonstrates active learning of the management of neuropathic pain through reflective practice.

Citing Articles

An Exploratory Analysis of Levels of Evidence for Articles Published in Indian Journal of Palliative Care in the years 2010-2011.

Kumar S, Sisodia V Indian J Palliat Care. 2013; 19(3):170-9.

PMID: 24347908 PMC: 3853396. DOI: 10.4103/0973-1075.121535.

References

Field M, McCleary S, Hughes J, Singh L . Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain. 1999; 80(1-2):391-8. DOI: 10.1016/s0304-3959(98)00239-5. View

Hayashida K, Eisenach J . Multiplicative interactions to enhance gabapentin to treat neuropathic pain. Eur J Pharmacol. 2008; 598(1-3):21-6. PMC: 2582977. DOI: 10.1016/j.ejphar.2008.09.004. View

Mercadante S, Fulfaro F, Casuccio A . A randomised controlled study on the use of anti-inflammatory drugs in patients with cancer pain on morphine therapy: effects on dose-escalation and a pharmacoeconomic analysis. Eur J Cancer. 2002; 38(10):1358-63. DOI: 10.1016/s0959-8049(02)00102-8. View

Freye E, Anderson-Hillemacher A, Ritzdorf I, Levy J . Opioid rotation from high-dose morphine to transdermal buprenorphine (Transtec) in chronic pain patients. Pain Pract. 2007; 7(2):123-9. DOI: 10.1111/j.1533-2500.2007.00119.x. View

Priano L, Gasco M, Mauro A . Transdermal treatment options for neurological disorders: impact on the elderly. Drugs Aging. 2006; 23(5):357-75. DOI: 10.2165/00002512-200623050-00001. View

Sittl R . Transdermal buprenorphine in the treatment of chronic pain. Expert Rev Neurother. 2005; 5(3):315-23. DOI: 10.1586/14737175.5.3.315. View

Bruera E, Kuehn N, Miller M, Selmser P, Macmillan K . The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991; 7(2):6-9. View

Fainsinger R, Nekolaichuk C, Lawlor P, Neumann C, Hanson J, Vigano A . A multicenter study of the revised Edmonton Staging System for classifying cancer pain in advanced cancer patients. J Pain Symptom Manage. 2005; 29(3):224-37. DOI: 10.1016/j.jpainsymman.2004.05.008. View

Battelli T, Bonsignori M, Manocchi P, Rossi G . Anxiety therapy in the neoplastic patient. Curr Med Res Opin. 1976; 4(3):185-8. DOI: 10.1185/03007997609109300. View

10.

Lussier D, Huskey A, Portenoy R . Adjuvant analgesics in cancer pain management. Oncologist. 2004; 9(5):571-91. DOI: 10.1634/theoncologist.9-5-571. View

11.

Attal N, Cruccu G, Baron R, Haanpaa M, Hansson P, Jensen T . EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010; 17(9):1113-e88. DOI: 10.1111/j.1468-1331.2010.02999.x. View

12.

Raja S, Haythornthwaite J, Pappagallo M, Clark M, Travison T, Sabeen S . Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2002; 59(7):1015-21. DOI: 10.1212/wnl.59.7.1015. View

13.

Oken M, Creech R, Tormey D, Horton J, Davis T, McFadden E . Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982; 5(6):649-55. View

14.

GREENBERG H, Kim J, Posner J . Epidural spinal cord compression from metastatic tumor: results with a new treatment protocol. Ann Neurol. 1980; 8(4):361-6. DOI: 10.1002/ana.410080404. View

15.

Zech D, Grond S, Lynch J, Hertel D, Lehmann K . Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain. 1995; 63(1):65-76. DOI: 10.1016/0304-3959(95)00017-M. View

16.

Bates M, Edwards T, Anderson K . Ethnocultural influences on variation in chronic pain perception. Pain. 1993; 52(1):101-112. DOI: 10.1016/0304-3959(93)90120-E. View

17.

Kroenke K, Krebs E, Bair M . Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. Gen Hosp Psychiatry. 2009; 31(3):206-19. DOI: 10.1016/j.genhosppsych.2008.12.006. View

18.

OConnor A . Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy. Pharmacoeconomics. 2009; 27(2):95-112. DOI: 10.2165/00019053-200927020-00002. View

19.

Pedersen L, Nielsen A, Blackburn-Munro G . Anti-nociception is selectively enhanced by parallel inhibition of multiple subtypes of monoamine transporters in rat models of persistent and neuropathic pain. Psychopharmacology (Berl). 2005; 182(4):551-61. DOI: 10.1007/s00213-005-0120-6. View

20.

Watanabe S, Bruera E . Corticosteroids as adjuvant analgesics. J Pain Symptom Manage. 1994; 9(7):442-5. DOI: 10.1016/0885-3924(94)90200-3. View